Intimation of schedule of Analysts/Institutional investors meet
Awaiting price reaction for this filing.
J.B. Chemicals & Pharmaceuticals has informed the stock exchanges that its management will participate in the Kotak India Conference in London on June 23–24, 2025. The meetings with analysts and institutional investors will be held physically as part of this conference. The company has explicitly stated that no Unpublished Price Sensitive Information (UPSI) will be shared during these interactions. The disclosure is filed under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements, 2015. The schedule remains subject to change due to unforeseen circumstances.
This is a routine compliance disclosure with no material impact on the stock price. Participation in a marquee institutional conference like Kotak India Conference may help improve analyst coverage and visibility among foreign institutional investors.